Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro
- PMID: 20406160
- PMCID: PMC3761975
- DOI: 10.2174/157488610790936150
Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro
Abstract
Black cohosh (Actaea racemosa L. [syn. Cimifuga racemosa L.]) extracts (BCE) are marketed worldwide for the management of menopausal symptoms. However, recently more than 75 cases of hepatotoxicity associated with black cohosh ingestion have been reported. While these cases have not been fully substantiated for causality, the data suggest that herb-drug interactions may be involved rather than a direct hepatotoxic event. This work describes the in vitro inhibition of four CYP450 enzymes (1A2, 2D6, 2C9, 3A4) by black cohosh extracts and identifies the active inhibitory constituents. Ethanol extracts (75 and 80% ethanol) and a 40% isopropanol extract induced a concentration-dependent inhibition of all CYP450 isozyme activities, with median inhibitory concentrations (IC(50)) ranging from 21.9 microg/ml to 65.0 microg/ml. Isolation of the active chemical constituents, showed that the triterpene glycosides were weakly active (IC(50) 25-100 microM), while fukinolic acid and cimicifugic acids A and B strongly inhibited all CYP isozymes (IC(50) 1.8-12.6 microM). None of the extracts inhibited the growth of Hep-G2 cells in concentrations up to 50 microg/ml. These data suggest that BCEs are not directly hepatotoxic, but may have the potential to induce herb-drug interactions, which may in turn explain the rare cases of hepatotoxicity observed in women using multiple medications and dietary supplements, including black cohosh.
Figures




Similar articles
-
Polyphenolic constituents of Actaea racemosa.J Nat Prod. 2006 Mar;69(3):314-8. doi: 10.1021/np0501031. J Nat Prod. 2006. PMID: 16562825
-
Chlorination diversifies Cimicifuga racemosa triterpene glycosides.J Nat Prod. 2007 Jun;70(6):1016-23. doi: 10.1021/np0700319. Epub 2007 Jun 8. J Nat Prod. 2007. PMID: 17555351 Free PMC article.
-
Inhibition of inducible nitric oxide synthesis by Cimicifuga racemosa (Actaea racemosa, black cohosh) extracts in LPS-stimulated RAW 264.7 macrophages.J Pharm Pharmacol. 2009 Aug;61(8):1089-96. doi: 10.1211/jpp/61.08.0013. J Pharm Pharmacol. 2009. PMID: 19703353
-
[Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].Ginekol Pol. 2008 Apr;79(4):287-96. Ginekol Pol. 2008. PMID: 18592868 Review. Polish.
-
Ethnobotany, Phytochemistry, Traditional and Modern Uses of Actaea racemosa L. (Black cohosh): A Review.Adv Exp Med Biol. 2021;1308:403-449. doi: 10.1007/978-3-030-64872-5_24. Adv Exp Med Biol. 2021. PMID: 33861455 Review.
Cited by
-
Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450.Int J Mol Sci. 2017 Nov 8;18(11):2353. doi: 10.3390/ijms18112353. Int J Mol Sci. 2017. PMID: 29117101 Free PMC article. Review.
-
Drug interactions with herbal medicines.Clin Pharmacokinet. 2012 Feb 1;51(2):77-104. doi: 10.2165/11597910-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22257149 Review.
-
In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4.Xenobiotica. 2011 Aug 9:10.3109/00498254.2011.603385. doi: 10.3109/00498254.2011.603385. Online ahead of print. Xenobiotica. 2011. PMID: 21827327 Free PMC article.
-
Pregnane X receptor-mediated induction of Cyp3a by black cohosh.Xenobiotica. 2011 Feb;41(2):112-23. doi: 10.3109/00498254.2010.527021. Epub 2010 Oct 27. Xenobiotica. 2011. PMID: 20979450 Free PMC article.
-
Estrogenic and serotonergic butenolides from the leaves of Piper hispidum Swingle (Piperaceae).J Ethnopharmacol. 2010 May 27;129(2):220-6. doi: 10.1016/j.jep.2010.03.008. Epub 2010 Mar 19. J Ethnopharmacol. 2010. PMID: 20304039 Free PMC article.
References
-
- Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiol Drug Saf. 2007;16:17–27. - PubMed
-
- Houmard BS, Seifer DB. Predicting the Onset of Menopause. In: Seifer DB, Kennard EA, editors. Menopause: Endocrinology and Management. Totwa, New Jersey: Humana Press; 1999. pp. 1–19.
-
- Doyle BJ, Mahady GB. Phytotherapies for menopause. Drugs of the Future. 2007;32:897–905.
-
- Locklear TD, Doyle BJ, Caceres A, Perez A, Mahady GB. Menopause a universal female experience: lessons from central america. Current Reviews in Women's Health. 2007;4:1–10.
-
- Mahady GB. Black cohosh (Actaea racemosa): review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol. 2005;4:177–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous